158th ASM: Dermatology Update
Virtual
Monday, October 23, 2023
6:00 PM - 8:00 PM
iCalendar
Eastern Standard Time
158th Annual Scientific Meeting (ASM) Virtual Monthly Series:
Dermatology Update
Live Virtual - Zoom
Monday, October 23, 2023
6:00 - 8:00 PM EST
This course will discuss IL-17A and IL-17F inhibitors across multiple disease pathways and implicit bias with a dermatology focus.
Objectives:
- Define the role of IL-17A and IL-17F inhibitors across multiple disease pathways and how therapies target this pathway.
- Discuss the benefit-risk profiles of IL-17 inhibitors across multiple inflammatory diseases.
- Discuss the differences between IL-17 inhibitors for the management of multiple inflammatory disease states.
- Describe strategies on how to individualize care for their patients with IL-17 inhibitors.
- Discuss strategies to reduce disparities in access to and delivery of health care services.
Co-Course Directors:
Steve Daveluy, MD; Kelly Harms, MD; Holly Kerr, MD; and Heather Orkwis, DO
Speakers:
Omar Qutub, MD, Defining Dermatology, Portland, OR
Combating Institutional Bias
Bruce Strober, MD
IL-17 Inhibitors for the mamagent of inflamatory conditions: What do we know today?
Selecting an appropriate IL-17 inhibitor for your patient with inflammatory diseases
Approved for 2 AMA PRA Category Credit(s)™
Registration Fee(s):
Members - $50
Non-Members - $75
Retired Members - $50
Member Students/Residents - FREE
Additional 158th MSMS Foundation Annual Scientific Meeting topics and dates include:
- August 28 - Updates in Endocrinology
- September 18 - Approach to Peripheral Neuropathy
- November 27 - Colon and Rectal Surgery Update
- December 18 - Allergy and Asthma Update
Statement of Accreditation:
The Michigan State Medical Society (MSMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The MSMS designates this live activity for a maximum of 2 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.